- Cefixime
-
Cefixime Systematic (IUPAC) name (6R,7R)-7-{[2-(2-amino-1,3-thiazol-4-yl)-2-(carboxy
methoxyimino)acetyl]amino}-3-ethenyl-8-oxo-5-thia-
1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acidClinical data Trade names Suprax AHFS/Drugs.com monograph MedlinePlus a690007 Pregnancy cat. B Legal status ? Routes Oral Pharmacokinetic data Bioavailability 40% to 50% Protein binding Approximately 60% Half-life Variable
Average 3 to 4 hoursExcretion Renal and biliary Identifiers CAS number 79350-37-1 ATC code J01DD08 PubChem CID 5362065 DrugBank APRD00583 ChemSpider 4514923 UNII 97I1C92E55 KEGG D00258 ChEBI CHEBI:472657 ChEMBL CHEMBL1541 Chemical data Formula C16H15N5O7S2 Mol. mass 453.452 g/mol SMILES eMolecules & PubChem (what is this?) (verify) Cefixime is an oral third generation cephalosporin antibiotic. Cefixime is a cephalosporin antibiotic used to treat infections caused by bacteria such as pneumonia; bronchitis; gonorrhea; and ear, lung, throat, and urinary tract infections. Antibiotics will not work for colds, flu, or other viral infections.
It was sold under the trade name Suprax in the USA until 2003 when it was taken off the market by drug manufacturer Wyeth after its patent expired. The oral suspension form of "Suprax" was re-launched by Lupin in the USA.
Cefixime API is manufactured by many pharmaceutical companies the world over. The major manufacturers are based in India.
References
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a690007.html
Categories:- Cephalosporin antibiotics
- Thiazoles
Wikimedia Foundation. 2010.